Diagnostic and Therapeutic Differences Between Immune Checkpoint Inhibitor–Induced and Idiopathic Bullous Pemphigoid
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Diagnostic and Therapeutic Differences Between Immune Checkpoint Inhibitor-Induced and Idiopathic Bullous Pemphigoid: A Cross-Sectional Study
Br J Dermatol 2020 Jun 12;[EPub Ahead of Print], GE Molina, KL Reynolds, ST ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.